GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » Dividend Payout Ratio

Halberd (Halberd) Dividend Payout Ratio : 0.00 (As of Jul. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Halberd Dividend Payout Ratio?

Halberd's dividend payout ratio for the months ended in Jul. 2023 was 0.00.

The historical rank and industry rank for Halberd's Dividend Payout Ratio or its related term are showing as below:


HALB's Dividend Payout Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 0.44
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-06-03), the Dividend Yield % of Halberd is 0.00%.

Halberd's Dividends per Share for the months ended in Jul. 2023 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Halberd Dividend Payout Ratio Historical Data

The historical data trend for Halberd's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd Dividend Payout Ratio Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
Dividend Payout Ratio
- - -

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
Dividend Payout Ratio - - -

Competitive Comparison of Halberd's Dividend Payout Ratio

For the Biotechnology subindustry, Halberd's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Halberd's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Halberd's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Halberd's Dividend Payout Ratio falls into.



Halberd Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Halberd's Dividend Payout Ratio for the fiscal year that ended in Jul. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Jul. 2023 )/ EPS without NRI (A: Jul. 2023 )
=0/ -0.001
=N/A

Halberd's Dividend Payout Ratio for the quarter that ended in Jul. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jul. 2023 )/ EPS without NRI (Q: Jul. 2023 )
=0/ -0.001
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Halberd (OTCPK:HALB) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Halberd Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Halberd's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Halberd (Halberd) Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.
Executives
John Christopher Maddox director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO 10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist director, 10 percent owner, officer: CEO, Secretary and Director 24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr. director 50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas director 280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236